- #1199196
- 23
- 默克# 00006432902
Vaxneuvance™ Pneumonia Vaccine Indicated for People 6 Weeks of Age and Older Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2 mcg - 4 mcg - 30 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
VAXNEUVANCE, SYR 0.5ML (1/BX)
Features
- VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
- Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
- Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
- More …
Product Details Email
Product Specifications
McKesson # | 1199196 |
Manufacturer # | 00006432902 |
Brand | Vaxneuvance™ |
Manufacturer | Merck |
Country of Origin | Ireland |
Application | Pneumonia Vaccine |
Container Type | Prefilled Syringe |
Dosage Form | Injection |
Generic Drug Code | 50034 |
Generic Drug Name | Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free |
NDC Number | 00006432902 |
Product Dating | McKesson Acceptable Dating: we will ship >= 180 days |
Storage Requirements | Requires Refrigeration |
Strength | 2 mcg - 4 mcg - 30 mcg / 0.5 mL |
Type | Intramuscular |
UNSPSC Code | 51201615 |
User | Indicated for People 6 Weeks of Age and Older |
Volume | 0.5 mL |
Features
- VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
- Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
- Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
Professionals Also Viewed
- #911398
- 1,118
- Merck #00006483703
- PNEUMOVAX 23 is a vaccine indicated for active immunization for the pr …
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older a …
- Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, co …
- #842097
- 280
- Pfizer #00005197105
- 在children 6 weeks through 5 years of age, Prevnar 13 is indicated fo …
- 在children Prevnar is also indicated for active immunization for the …
- No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, …
- #795986
- 1,026
- Pfizer #00005197102
- 在children 6 weeks through 5 years of age, Prevnar 13 is indicated fo …
- 在children Prevnar is also indicated for active immunization for the …
- No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, …